BCL2 and prostate carcinoma: In prostatic cancer, TTN‐AS1 could negatively interact with miR‐193a‐5p, which then adjusted the protein levels of p21, Bax, CyclinD1, and Bcl‐2 to involve in cell apoptosis and proliferation.39